Andrew J. Ocque

815 citations

19 papers · 678 indexed · 1 hit paper · h-index 11

Nephrology top 5%
Biological Psychiatry top 10%
Reproductive Medicine top 10%
- Ovarian function and disorders 2
Clinical Biochemistry top 10%
Physiology
Infectious Diseases
- HIV/AIDS drug development and treatment 7
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 4
Pharmacology
- Pharmacogenetics and Drug Metabolism 3
Hepatology
- Hepatitis C virus research 3
Virology
- HIV Research and Treatment 2
Oncology
- Drug Transport and Resistance Mechanisms 2
Biochemistry
- Eicosanoids and Hypertension Pharmacology 2

Co-authors: Thomas D. Nolin Jason R. Stubbs John A. House John A. Spertus Shiqin Zhang Aditi Gupta Alan S.L. Yu James B. Wetmore
Cited by: Nephrology Biological Psychiatry Reproductive Medicine
Partner nations: United States Canada Zimbabwe

In The Last Decade

Andrew J. Ocque

19 papers receiving 663 citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden

Peers

Countries citing papers authored by Andrew J. Ocque

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Ocque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Ocque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Ocque more than expected).

Fields of papers citing papers by Andrew J. Ocque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Ocque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Ocque. The network helps show where Andrew J. Ocque may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew J. Ocque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew J. Ocque Line = papers co-authored together Andrew J. Ocque links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Effect of Dolutegravir and Sertraline on the Blood Brain Barrier (BBB) Qing Ma,Giovanni Schifitto,Charles S. Venuto,Andrew J. Ocque,Stephen Dewhurst,Gene D. Morse,Ravikumar Aalinkeel,Stanley A. Schwartz,Supriya D. Mahajan	2020	6
2	Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited setting Faithful Makita-Chingombe,Andrew J. Ocque,Robin DiFrancesco,Charles C. Maponga,Farai Muzambi,Tsitsi G. Monera-Penduka,Tinashe Mudzviti,Takudzwa J. Mtisi,Gene D. Morse	2019	2
3	Development and validation of an assay to measure cannabidiol and Δ9-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS/MS Andrew J. Ocque,Colleen E. Hagler,Robin DiFrancesco,Jeffrey Lombardo,Gene D. Morse	2019	17
4	Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid Qing Ma,Andrew J. Ocque,Gene D. Morse,Chelsea Sanders,Alina Burgi,Susan J. Little,Scott Letendre	2019	8
5	Development and validation of an LC–MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid Andrew J. Ocque,Colleen E. Hagler,Gene D. Morse,Scott Letendre,Qing Ma	2018	26
6	Development and validation of a UHPLC–MS/MS assay for elvitegravir measurement in human plasma and cerebrospinal fluid Andrew J. Ocque,Colleen E. Hagler,Jill Lapham,Gene D. Morse,Scott Letendre,Qing Ma	2018	2
7	Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates Andrew J. Ocque,Colleen E. Hagler,Robin DiFrancesco,Gene D. Morse,Andrew H. Talal	2017	14
8	Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage Andrew H. Talal,Emily O. Dumas,Barbara Bauer,Richard M Rejman,Andrew J. Ocque,Gene D. Morse,Danijela Lucic,Gavin Cloherty,Jennifer R. King,Jiuhong Zha,Hongtao Zhang,Daniel E. Cohen,Nancy S. Shulman,Jean–Michel Pawlotsky,Christophe Hézode	2017	6
9	Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques Charles S. Venuto,Marianthi Markatou,Yvonne Woolwine-Cunningham,Rosemary L. Furlage,Andrew J. Ocque,Robin DiFrancesco,Emily O. Dumas,Paul K. Wallace,Gene D. Morse,Andrew H. Talal	2017	4
10	The effect of ribavirin dosage on the kinetics of viral load decline and drug exposures in plasma and liver with OBV/PTV/r + DSV treatment in patients with chronic hepatitis C virus genotype 1a infection Andrew H. Talal,Emily O. Dumas,Brenton Bauer,Richard M Rejman,Andrew J. Ocque,G D Morse,Danijela Lucic,Gavin Cloherty,John W. King,H. Zhang,David E. Cohen,Nancy S. Shulman,Jean–Michel Pawlotsky,C. Hézode	2017	1
11	Development and Validation of A UPLC–MS/MS Method for The Simultaneous Determination of Paritaprevir and Ritonavir in Rat Liver Andrew J. Ocque,Colleen E. Hagler,Robin DiFrancesco,Yvonne Woolwine-Cunningham,Cindy J. Bednasz,Gene D. Morse,Andrew H. Talal	2016	12
12	Development and validation of a simple UHPLC–MS/MS method for the simultaneous determination of trimethylamine N-oxide, choline, and betaine in human plasma and urine Andrew J. Ocque,Jason R. Stubbs,Thomas D. Nolin	2015	58
13	Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burdenbreakdown → Jason R. Stubbs,John A. House,Andrew J. Ocque,Shiqin Zhang,Cassandra Johnson,Cassandra Kimber,Kyle Schmidt,Aditi Gupta,James B. Wetmore,Thomas D. Nolin,John A. Spertus,Alan S.L. Yu	2015	358
14	Validation and Application of a Simple UHPLC–MS-MS Method for the Enantiospecific Determination of Warfarin in Human Urine Osama Y. Alshogran,Andrew J. Ocque,Agnès Leblond,Vincent Pichette,Thomas D. Nolin	2015	6
15	Effect of Experimental Kidney Disease on the Functional Expression of Hepatic Reductases Osama Y. Alshogran,Judith Naud,Andrew J. Ocque,Agnès Leblond,Vincent Pichette,Thomas D. Nolin	2014	12
16	Determination of warfarin alcohols by ultra-high performance liquid chromatography–tandem mass spectrometry: Application to in vitro enzyme kinetic studies Osama Y. Alshogran,Andrew J. Ocque,Jielu Zhao,Billy W. Day,François A. Leblond,Vincent Pichette,Thomas D. Nolin	2013	14
17	Correlations of follicular fluid oxidative stress biomarkers and enzyme activities with embryo morphology parameters during in vitro fertilization Victor Y. Fujimoto,Michael S. Bloom,Heather G. Huddleston,Wendy B. Shelley,Andrew J. Ocque,Richard W. Browne	2011	43
18	Follicular fluid high density lipoprotein-associated micronutrient levels are associated with embryo fragmentation during IVF Richard W. Browne,Michael S. Bloom,Wendy Shelly,Andrew J. Ocque,Heather G. Huddleston,Victor Y. Fujimoto	2009	36
19	Distributions of high-density lipoprotein particle components in human follicular fluid and sera and their associations with embryo morphology parameters during IVF Richard W. Browne,Wendy Shelly,Michael S. Bloom,Andrew J. Ocque,J.R. Sandler,Heather G. Huddleston,Victor Y. Fujimoto	2008	53

About Andrew J. Ocque

Andrew J. Ocque is a scholar working on Virology, Biochemistry and Infectious Diseases, having authored 19 papers that have together received 678 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), Pharmacological Effects and Toxicity Studies (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Hepatitis C virus research (3 papers), HIV Research and Treatment (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Ovarian function and disorders (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Nephrology (106 citations), Biological Psychiatry (34 citations) and Reproductive Medicine (79 citations). Andrew J. Ocque has collaborated with scholars based in United States, Canada and Zimbabwe. Frequent co-authors include Thomas D. Nolin, Jason R. Stubbs, John A. House, John A. Spertus, Shiqin Zhang, Aditi Gupta, Alan S.L. Yu, James B. Wetmore, Cassandra Johnson and Victor Y. Fujimoto.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact